COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
This invention relates to novel diarylamino compounds that bind to the sigma-2 receptor, to pharmaceutical compositions comprising such compounds, and to methods for inhibiting or restoring synapse loss in neuronal cells, modulating a membrane trafficking
-
Paragraph 0520-0525
(2017/08/01)
Inhibitors of cognitive decline
Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
-
Page/Page column 34; 35
(2016/09/26)
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
This invention relates to novel diarylamino compounds that bind to the sigma-2 receptor, to pharmaceutical compositions comprising such compounds, and to methods for inhibiting or restoring synapse loss in neuronal cells, modulating a membrane trafficking
-
Paragraph 04003
(2013/03/26)
More Articles about upstream products of 1247013-23-5